tecalcet
| SMILES | COc1cccc(c1)[C@H](NCCCc1ccccc1Cl)C |
| InChIKey | ZVQUCWXZCKWZBP-CQSZACIVSA-N |
Chemical properties
| Hydrogen bond acceptors | 2 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 7 |
| Molecular weight (Da) | 303.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CaS | CASR | Human | Calcium-sensing | C | pKd | 6.5 | 6.5 | 6.5 | Guide to Pharmacology |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.02 | 6.02 | 6.02 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 5.8 | 5.8 | 5.8 | ChEMBL |
| H2 | HRH2 | Human | Histamine | A | pKi | 5.85 | 5.85 | 5.85 | ChEMBL |
| H1 | HRH1 | Human | Histamine | A | pKi | 6.04 | 6.04 | 6.04 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 5.63 | 5.63 | 5.63 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 7.37 | 7.37 | 7.37 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.79 | 6.79 | 6.79 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 5.84 | 5.84 | 5.84 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 6.06 | 6.06 | 6.06 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 5.85 | 5.85 | 5.85 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 5.66 | 5.66 | 5.66 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.74 | 6.74 | 6.74 | ChEMBL |
| 5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 5.96 | 5.96 | 5.96 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CaS | CASR | Human | Calcium-sensing | C | pKB | 6.2 | 6.4 | 6.6 | Guide to Pharmacology |
| CaS | CASR | Human | Calcium-sensing | C | pEC50 | 6.71 | 6.97 | 7.1 | ChEMBL |